Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Summary Weight management dosing targets higher, sustained exposures than diabetes regimens, with typical semaglutide weekly doses ranging from 0.25 mg up to 2.4 mg and average weight loss around 15% over 18 months in reported programs
Weight-loss outcome assumptions (15% average reduction in body weight over 12 months) were based on results from the STEP 1 and SURMOUNT 1 clinical trials
At NuLevel Wellness Medspa, semaglutide is utilized as part of a comprehensive approach to health and wellness
medical benefit and how this structure impacts insurance coverage for GLP-1 drugs for diabetes and obesity, including the 20252026 Medicare BALANCE Model, manufacturer price cuts, and employer coverage trends
Esta clase de medicamentos imita la accin del GLP-1, una hormona que desempea un papel crucial en el metabolismo de la glucosa y la regulacin del apetito
US$ 26.36
US$ 20.28
US$ 20.37
US$ 20.56
